REQUEST A DEMO
Total
USD $0.00
Search more companies

L.B. Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: L.B. Pharma Gyogyszer-kiskereskedelmi Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

L.B. Pharma Kft. is based in Hungary. The head office is in Budapest. It operates in the Pharmacies and Drug Stores industry. It was incorporated on February 17, 2009. It currently has a total number of 9 (2024) employees. There was a net sales revenue increase of 6.9% reported in L.B. Pharma Kft.’s latest financial highlights for 2023. Its total assets grew by 24.38% over the same period. The net profit margin of L.B. Pharma Kft. decreased by 3.54% in 2023.

Headquarters
Duna utca 1-3.
Budapest; Budapest; Postal Code: 1221

Contact Details: Purchase the L.B. Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the L.B. Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the L.B. Pharma Kft. report to view the information.
Registered Capital:
Purchase the L.B. Pharma Kft. report to view the information.
Financial Auditors:
Purchase the L.B. Pharma Kft. report to view the information.
Incorporation Date:
February 17, 2009
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after L.B. Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
6.9%
Total operating revenue
2.33%
Operating profit (EBIT)
-29.78%
EBITDA
-27.49%
Net Profit (Loss) for the Period
-29.93%
Total assets
24.38%
Total equity
0.3%
Operating Profit Margin (ROS)
-3.82%
Net Profit Margin
-3.54%
Return on Equity (ROE)
-7.65%
Quick Ratio
-2.02%
Cash Ratio
-0.6%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?